NASDAQ:ZYNE

Zynerba Pharmaceuticals SEC Filings & 10K Form

$3.93
-0.04 (-1.01 %)
(As of 04/19/2021 01:46 PM ET)
Add
Compare
Today's Range
$3.83
Now: $3.93
$4.09
50-Day Range
$4.03
MA: $4.63
$7.03
52-Week Range
$3.12
Now: $3.93
$9.00
Volume31,573 shs
Average Volume4.87 million shs
Market Capitalization$162.12 million
P/E RatioN/A
Dividend YieldN/A
Beta2.83

SEC Filings

Zynerba Pharmaceuticals (NASDAQ:ZYNE) SEC Filings

DateFilerForm TypeView
03/11/2021
10:12 AM
ETF MANAGERS GROUP, LLC (Filed by)
Zynerba Pharmaceuticals (Subject)
Form SC 13G/A
03/10/2021
6:16 AM
Zynerba Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/10/2021
6:00 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2021
3:22 PM
Fickenscher James E (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
3:21 PM
ANIDO ARMANDO (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
3:19 PM
Sebree Terri B (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
3:15 PM
Rosenberger Brian (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2021
3:14 PM
Hanlon Suzanne M. (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2021
12:04 PM
ETF MANAGERS GROUP, LLC (Filed by)
Zynerba Pharmaceuticals (Subject)
Form SC 13G/A
12/17/2020
6:01 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/04/2020
11:30 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2020
11:05 AM
ETF MANAGERS GROUP, LLC (Filed by)
Zynerba Pharmaceuticals (Subject)
Form SC 13G/A
11/09/2020
6:31 AM
Zynerba Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2020
6:16 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2020
6:16 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2020
3:15 PM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/17/2020
3:05 PM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2020
6:01 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/10/2020
5:45 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/22/2020
6:00 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/30/2020
5:50 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2020
4:42 PM
COOPER WARREN D (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
4:40 PM
Butler John P. (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
4:38 PM
FEDERICI WILLIAM J (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
4:36 PM
Stephenson Pamela (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
4:34 PM
KISNER DANIEL L (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2020
4:30 PM
MOCH KENNETH I (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
3:12 PM
Zynerba Pharmaceuticals (Filer)
Form 8-K/A
06/02/2020
6:30 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/27/2020
6:10 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/26/2020
6:15 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/21/2020
7:00 AM
Zynerba Pharmaceuticals (Filer)
Form DEFA14A
05/11/2020
1:43 PM
ETF MANAGERS GROUP, LLC (Filed by)
Zynerba Pharmaceuticals (Subject)
Form SC 13G/A
05/11/2020
7:01 AM
Zynerba Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/11/2020
6:00 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2020
8:03 AM
Zynerba Pharmaceuticals (Filer)
Form DEFA14A
04/23/2020
8:00 AM
Zynerba Pharmaceuticals (Filer)
Form DEF 14A
04/15/2020
6:30 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2020
6:16 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/10/2020
6:12 AM
Zynerba Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/03/2020
11:15 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2020
6:00 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/25/2020
6:31 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2020
6:00 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
6:00 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/02/2019
12:37 PM
ETF MANAGERS GROUP, LLC (Filed by)
Zynerba Pharmaceuticals (Subject)
Form SC 13G/A
11/06/2019
7:16 AM
Zynerba Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
6:00 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
3:05 PM
MOCH KENNETH I (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/24/2019
6:04 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2019
6:14 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/30/2019
3:27 PM
Zynerba Pharmaceuticals (Filer)
Form 424B5
08/30/2019
3:01 PM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2019
11:15 PM
Zynerba Pharmaceuticals (Filer)
Form EFFECT
08/06/2019
7:13 AM
Zynerba Pharmaceuticals (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/06/2019
6:04 AM
Zynerba Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/06/2019
6:00 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2019
1:13 PM
MOCH KENNETH I (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:23 PM
MOCH KENNETH I (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:22 PM
Stephenson Pamela (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:20 PM
COOPER WARREN D (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:19 PM
Butler John P. (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:18 PM
FEDERICI WILLIAM J (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2019
3:16 PM
KISNER DANIEL L (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/12/2019
3:15 PM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2019
8:41 AM
ETF MANAGERS GROUP, LLC (Filed by)
Zynerba Pharmaceuticals (Subject)
Form SC 13G
05/29/2019
6:00 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2019
8:01 AM
Zynerba Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2019
6:30 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
3:35 PM
Zynerba Pharmaceuticals (Filer)
Form DEFA14A
05/06/2019
3:31 PM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2019
6:31 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2019
8:02 AM
Zynerba Pharmaceuticals (Filer)
Form DEFA14A
04/25/2019
8:01 AM
Zynerba Pharmaceuticals (Filer)
Form DEF 14A
04/03/2019
6:35 AM
MOCH KENNETH I (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2019
8:16 AM
Zynerba Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/11/2019
8:01 AM
Zynerba Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/11/2019
6:00 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2019
6:00 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2019
7:11 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2019
3:10 PM
Stephenson Pamela (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2019
7:37 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2019
3:12 PM
ANIDO ARMANDO (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4/A
01/29/2019
11:41 AM
GENESIS CAPITAL ADVISORS LLC (Filed by)
Zynerba Pharmaceuticals (Subject)
Form SC 13G/A
01/28/2019
3:20 PM
Hanlon Suzanne M. (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
3:20 PM
Sebree Terri B (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
3:15 PM
ANIDO ARMANDO (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
3:14 PM
Fickenscher James E (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/28/2019
3:14 PM
Rosenberger Brian (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/15/2019
3:43 PM
RAPP MICHAEL (Filed by)
Zynerba Pharmaceuticals (Subject)
Form SC 13G/A
01/04/2019
9:10 AM
MOCH KENNETH I (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/04/2019
6:03 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
6:31 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/12/2018
4:16 PM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
7:40 AM
Zynerba Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
5:45 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2018
3:24 PM
FEDERICI WILLIAM J (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2018
3:22 PM
MOCH KENNETH I (Reporting)
Zynerba Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2018
11:00 PM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2018
6:31 AM
Zynerba Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.